Skip to main content
Caplight Logo









Limax Biosciences

Limax Biosciences

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://www.limaxbiosciences.com/

Last Round

Grant

Oct 1, 2025

Total Funding Raised

$200,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Limax Biosciences is a therapeutic devices company that develops a degradable adhesive hydrogel for hemostasis, wound closure, and drug delivery.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

hydrogel adhesivesurgical adhesivewound sealanttissue adhesivebiomimicryhemostatic agentwet tissue adhesionslug-inspired adhesivemedical devicemedical gluebiomaterialslocal drug deliverysoft tissue repairpostpartum hemorrhagePPHwound closure

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Limax Biosciences Comparables

Compare Limax Biosciences with similar companies based on industry and business-model similarity.

Limax Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AsparaGlue
84%
Sealonix, Inc.
82%
Cresilon
78%

Limax Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 1, 2025
AngelMar 25, 2025
AcceleratorFeb 16, 2023
GrantSep 1, 2022
AcceleratorJun 7, 2022
Grant
May 5, 2022

Limax Biosciences Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 15, 2026

    Grew 50% QoQ from 6 to 9 employees.

  • Apr 21, 2026

    Monthly visitors grew 467% MoM, from 283 to 1.6K.

Limax Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Limax Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Limax Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range13
Year Founded2021
Last FundingOct 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.